Lonafarnib in Metastatic Breast Cancer

NCT00773474 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

29

Enrollment

OTHER

Sponsor class

Stopped funding terminated

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Lonafarnib

Sponsor

George Sledge

Collaborators

[object Object]
[object Object]